SourceOne and PenRad become US distribution partners:
This article was originally published in Clinica
Executive Summary
SourceOne Healthcare Technologies has won US distribution rights to PenRad's Mammography Information Systems, which are designed to "decrease workload, increase efficiency, improve accuracy and provide immediate turnaround time". The agreement will allow Mentor, Ohio-based SourceOne to offer a more comprehensive solution for women's healthcare, while PenRad, of Plymouth, Minnesota, will benefit from its partner's sales team dedicated to this market.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.